Early uptake for oral semaglutide proves rapid relative to injectables
Early uptake was rapid for oral semaglutide (Wegovy pill) relative to injectable incretin-based weight management therapies, according to a study published online Oct. 13 in Annals of Internal Medicine.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Clinical support tool helps primary care health professionals detect and treat chronic kidney disease
United Kingdom
-
Potassium binder may ease the burden of dietary potassium restriction in people on dialysis
United Kingdom
-
Fruits and vegetables outperform medication for treating metabolic acidosis in chronic kidney disease
United Kingdom
-
Social determinants linked with kidney failure risk among survivors of critical illness and acute kidney injury
United Kingdom
-
Standardized kidney biopsy protocol is safe in high-risk patients
United Kingdom
-
US cannabis legalization linked to rise in cardiovascular hospital admissions
United Kingdom
-
Beyond the ACE score: A single number may miss the complexity of childhood trauma, study suggests
United Kingdom
-
ADHD medication unlikely to raise risk of self-harm, international study finds
United Kingdom